|
|
Interventional study compares VitaGraft to current transplant rejection monitoring protocolsOncocytes VitaGraft assay detects antibodymediated transplant rejection 10 months sooner than commonly used monitoring protocols p<0.001IRVINE, CA / ACCESSWIRE / September 18, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, today announ... Lire le communiqué |
|
| |
|
| |
|
|
First digitaldroplet PCR assay to receive coverageExpect initial revenue generation in Q1 2024IRVINE, CA / ACCESSWIRE / August 28, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services CMS, has issued a positive... Lire le communiqué |
|
| |
|
| |
|
|
Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ETIRVINE, CA / ACCESSWIRE / August 10, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023.Second Quarter and Recent HighlightsTransplant product launch on pace for Q4 early access. M... Lire le communiqué |
|
| |
|
| |
|
|
IRVINE, CA / ACCESSWIRE / August 9, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market "Nasdaq" stating that the Company has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed.The Company... Lire le communiqué |
|
| |
|
| |
|
|
CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023IRVINE, CA / ACCESSWIRE / August 8, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, announced today that it will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference taking place on August 1415th, 2023.Josh Riggs, CEO of Oncocyte, will be meeting 1x1... Lire le communiqué |
|
| |
|
| |
|
|
Conference Call and Webcast on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ETIRVINE, CA / ACCESSWIRE / August 3, 2023 / Oncocyte Corporation NASDAQ:OCX, a precision diagnostics company, announced today that it will release its second quarter 2023 financial results on Thursday, August 10, 2023, prior to the U.S. market open. The company will host a conference call and webcast on... Lire le communiqué |
|
| |
|
| |
